Status:
UNKNOWN
Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors
Lead Sponsor:
Universidad Antonio de Nebrija
Collaborating Sponsors:
Hospital de la Ribera
Conditions:
Breast Cancer
Cognitive Decline
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The present study aims to establish a non-pharmacological alternative in alleviating cognitive deterioration derived from undergoing chemotherapy treatment. Thus, the effectiveness of a personalized a...
Detailed Description
A phase I/II/III clinical trial is proposed in which the first two phases will serve to evaluate the safety of the intervention and the maximum tolerated time of computerized cognitive training per se...
Eligibility Criteria
Inclusion
- Have been diagnosed with breast cancer.
- Having undergone chemotherapy.
- Report objective or subjective complaints of cognitive impairment.
Exclusion
- Metastases or brain tumors.
- Existence of a relevant medical, psychiatric, or neurological disorder.
- Significant visual or motor impairments.
- History of alcohol or drug abuse or dependence.
- Be receiving another cognitive stimulation intervention.
Key Trial Info
Start Date :
June 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05409248
Start Date
June 3 2022
End Date
December 1 2023
Last Update
June 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital la Ribera
Alzira, Valencia, Spain, 46600